219 related articles for article (PubMed ID: 16563782)
21. Determination of 226Ra in urine samples by alpha spectrometry.
Kehagia K; Potiriadis C; Bratakos S; Koukouliou V; Drikos G
Radiat Prot Dosimetry; 2007; 127(1-4):293-6. PubMed ID: 17827131
[TBL] [Abstract][Full Text] [Related]
22. Radiopharmaceutical chemistry of targeted radiotherapeutics, Part 3: alpha-particle-induced radiolytic effects on the chemical behavior of (211)At.
Pozzi OR; Zalutsky MR
J Nucl Med; 2007 Jul; 48(7):1190-6. PubMed ID: 17574991
[TBL] [Abstract][Full Text] [Related]
23. Direct procedure for the production of 211At-labeled antibodies with an epsilon-lysyl-3-(trimethylstannyl)benzamide immunoconjugate.
Lindegren S; Frost S; Bäck T; Haglund E; Elgqvist J; Jensen H
J Nucl Med; 2008 Sep; 49(9):1537-45. PubMed ID: 18703591
[TBL] [Abstract][Full Text] [Related]
24. A sequential method for the determination of 210Pb, 226Ra, and uranium and thorium radioisotopes by LSC and alpha-spectrometry.
Lozano JC; Tomé FV; Rodríguez PB; Prieto C
Appl Radiat Isot; 2010; 68(4-5):828-31. PubMed ID: 19833528
[TBL] [Abstract][Full Text] [Related]
25. 210Po and 210Pb inhalation by cigarette smoking in Italy.
Desideri D; Meli MA; Feduzi L; Roselli C
Health Phys; 2007 Jan; 92(1):58-63. PubMed ID: 17164600
[TBL] [Abstract][Full Text] [Related]
26. Concept for an off-line gain stabilisation method.
Pommé S; Sibbens G
Appl Radiat Isot; 2004; 60(2-4):151-4. PubMed ID: 14987634
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of an internal cyclotron target for the production of 211At via the 209Bi (alpha,2n)211 at reaction.
Larsen RH; Wieland BW; Zalutsky MR
Appl Radiat Isot; 1996 Feb; 47(2):135-43. PubMed ID: 8852627
[TBL] [Abstract][Full Text] [Related]
28. Determination of 210Po in environmental materials: a review of analytical methodology.
Matthews KM; Kim CK; Martin P
Appl Radiat Isot; 2007 Mar; 65(3):267-79. PubMed ID: 17118667
[TBL] [Abstract][Full Text] [Related]
29. TASTRAK spectroscopy of polonium-210 alpha-particle activity at bone surfaces: evidence for a concentrated surface deposit less than 3 microns deep.
Salmon PL; Henshaw DL; Keitch PA; Allen JE; Fews AP
Radiat Res; 1994 Oct; 140(1):63-71. PubMed ID: 7938456
[TBL] [Abstract][Full Text] [Related]
30. Prompt detection of alpha particles from 210Po: another clue to the origin of rock varnish?
Hodge VF; Farmer DE; Diaz T; Orndorff RL
J Environ Radioact; 2005; 78(3):331-42. PubMed ID: 15511566
[TBL] [Abstract][Full Text] [Related]
31. Absolute counting of 188Re radiopharmaceuticals.
Yuan MC; Pang HF; Wang CF
Appl Radiat Isot; 2006; 64(10-11):1380-3. PubMed ID: 16556500
[TBL] [Abstract][Full Text] [Related]
32. A novel technique for the rapid identification of alpha emitters released during a radiological incident.
Dilbeck GA; Taylor B; Leitch J; Silverstone M; Moore B; Honsa P
Health Phys; 2006 Oct; 91(4):311-7. PubMed ID: 16966874
[TBL] [Abstract][Full Text] [Related]
33. An experimental analysis of some of the factors affecting gross alpha-particle activity with an emphasis on 226Ra and its progeny.
Arndt MF; West LE
Health Phys; 2007 Feb; 92(2):148-56. PubMed ID: 17220716
[TBL] [Abstract][Full Text] [Related]
34. Radiopharmaceutical chemistry of targeted radiotherapeutics, Part 2: radiolytic effects of 211At alpha-particles influence N-succinimidyl 3-211AT-astatobenzoate synthesis.
Pozzi OR; Zalutsky MR
J Nucl Med; 2005 Aug; 46(8):1393-400. PubMed ID: 16085599
[TBL] [Abstract][Full Text] [Related]
35. Cross-section measurement of the 169 Tm p,n reaction for the production of the therapeutic radionuclide 169 Yb and comparison with its reactor-based generation.
Spahn I; Takács S; Shubin YN; Tárkányi F; Coenen HH; Qaim SM
Appl Radiat Isot; 2005 Aug; 63(2):235-9. PubMed ID: 15919210
[TBL] [Abstract][Full Text] [Related]
36. Concentration levels of 210Pb and 210Po in dry tobacco leaves in Greece.
Savidou A; Kehagia K; Eleftheriadis K
J Environ Radioact; 2006; 85(1):94-102. PubMed ID: 16098642
[TBL] [Abstract][Full Text] [Related]
37. Measurements of the half-life of 214Po and 218Rn using digital electronics.
Suliman G; Pommé S; Marouli M; Van Ammel R; Jobbágy V; Paepen J; Stroh H; Apostolidis C; Abbas K; Morgenstern A
Appl Radiat Isot; 2012 Sep; 70(9):1907-12. PubMed ID: 22436449
[TBL] [Abstract][Full Text] [Related]
38. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
[TBL] [Abstract][Full Text] [Related]
39. Radiopharmaceutical chemistry of targeted radiotherapeutics, part 4: Strategies for
Pozzi OR; Zalutsky MR
Nucl Med Biol; 2017 Mar; 46():43-49. PubMed ID: 28013121
[TBL] [Abstract][Full Text] [Related]
40. High-resolution alpha-particle spectrometry of the 230U decay series.
Marouli M; Pommé S; Paepen J; Van Ammel R; Jobbágy V; Dirican A; Suliman G; Stroh H; Apostolidis C; Abbas K; Morgenstern A
Appl Radiat Isot; 2012 Sep; 70(9):2270-4. PubMed ID: 22424835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
